- Product Details
Keywords
- High purity Omeprazole for digestive system CAS NO.73590-58-6
- purity 99% Omeprazole
- 73590-58-6
Quick Details
- ProName: API omeprazole pellets powder
- CasNo: 73590-58-6
- Molecular Formula: C17H19N3O3S
- Appearance: white crystalline solid
- Application: API
- DeliveryTime: To be negotiated
- PackAge: 25kg/drum
- Port: any port of China
- ProductionCapacity: 1000 Kilogram/Week
- Purity: 99%
- Storage: Dry, ventilated
- Transportation: By sea,by air,by express
- LimitNum: 10 Gram
- Grade: Pharma Grade
Superiority
Details
Basic information
Product Name: |
|
Synonyms: |
1h-benzimidazole,5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulf;2-Chloromethyl-3,5-dinmethyl-4-methoxypyridine;5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazol;audazol;aulcer;belmazol;ceprandal;elgam |
CAS: |
|
MF: |
C17H19N3O3S |
MW: |
345.42 |
Product Categories: |
Drug bulk;Active Pharmaceutical Ingredients;Omeprazole;Intermediates & Fine Chemicals;Pharmaceuticals;API's;ATPase;Metabolite Reference Standard;Isotopically Labeled Pharmaceutical Reference Standard;OSMITROL;Other APIs;Digestive System |
Mol File: |
|
|
Chemical Properties |
melting point |
156°C |
boiling point |
599.991 °C at 760 mmHg |
density |
1.371 g/cm3 |
flashing ponit |
316.663 °C |
storage temp. |
2-8°C |
solubility |
H2O: 0.5 mg/mL |
stability |
Stable, but hygroscopic and photosensitive. Incompatible with strong oxidizing agents. Store in the dark. |
Usage And Synthesis |
Chemical Properties |
White Crystalline Solid |
Usage |
Binds covalently to proton pump. It inhibits gastric secretion. Used as an anttiulcerative |
diuretic, sweetener, diagnostic aid |
|
A selective proton pump and CYP inhibitor |
|
Omeprazole Pellets are used in the treatment of Gastroesophageal reflux disease (GERD): A condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus) |
|
Biological Activity |
H + ,K + -ATPase inhibitor (IC 50 = 5.8 μ M) that displays antisecretory and antiulcer activity. Inhibits gastric acid secretion (IC 50 = 0.16 μ M for histamine-induced acid formation) and reduces gastric lesion formation induced by a variety of ulcerative stimuli. Antibacteral against Helicobacter pylori in vitro . Also inhibits CYP2C19, CYP2C9 and CYP3A (K i values are 3.1, 40.1 and 84.4 μ M respectively) and blocks swelling-dependent chloride channels (ICIswell). |